Biotech company in Tampa developing bacterial-based therapies.

Cardeas Pharma: Specializing in developing inhaled antibiotics for respiratory infections.

Biofrontera Inc.: A biopharmaceutical firm specializing in sun damage skin therapies in the US.

Revagenix: A San Mateo-based biopharmaceutical company innovating therapies for medical needs.

Antibiotic Adjuvant: Intelligent system for coordinating antibiotic usage.

BioRelix Inc: A leading manufacturer and distributor of innovative antibiotic drugs and riboswitch-based therapies.

Geom Therapeutics, a biotech firm, develops novel antibiotics for multidrug-resistant infections.

Atterx, based in Wisconsin, pioneers innovative therapeutics to combat antibiotic-resistant bacteria globally.

Innovative Menlo Park-based medical organization developing novel antibiotics for drug-resistant bacteria.

Prokaryotics: A biopharmaceutical start-up optimizing Merck's early-stage antibiotic programs.

Elitra Pharmaceuticals Inc. pioneers in developing novel antibiotic and antifungal drugs using advanced genomics.

Arixa Pharmaceuticals: Innovating oral antibiotics for resistant Gram-negative infections.

Seoul-based HANALL BIOPHARMA CO., LTD. specializes in manufacturing prescription antibiotics and amino-acid infusions.

Pittsburgh-based Ahemet Antidotes develops organic livestock antibiotics to combat antibiotic resistance.

Innovative antibiotics for Gram-negative infections by Valanbio Therapeutics in Raleigh, NC.

Curza: A therapeutics company innovating in antibiotics and oncology with proprietary drugs.

US-based Spero Therapeutics develops and commercializes novel treatments for MDR bacterial infections.

Kukje Pharma Co., Ltd. manufactures and supplies a range of medical drugs, including antibiotics and vitamins.

NovoBiotic Pharmaceuticals: A private American biotech firm specializing in discovery and development.

IASO Pharma, Inc.: A biopharmaceutical firm developing and distributing antibiotics to treat infections.

Summit Therapeutics Inc., a biopharmaceutical firm, develops novel antibiotics for infectious diseases in the US and UK.

SelectX Pharmaceuticals Inc.: Boston-based biopharmaceutical firm developing advanced aminoglycoside therapeutics for unmet medical needs.

Validus Cellular Therapeutics develops immune-activating antibiotics for infectious diseases and respiratory disorders.

X-Biotix Therapeutics: A biotech firm innovating antibiotic solutions for multi-drug-resistant pathogens.

RQx Pharmaceuticals: A California-based biopharmaceutical firm innovating broad-spectrum antibiotics since 2010.